FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Geertruida Kolfschoten

Research Profile

Anatomy

Tumor Cells, Cultured

Disorders

Ovarian Neoplasms

Chemicals & Drugs

Living Beings

Procedures

Physiology

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Geertruida M Kolfschoten; Bérengère Pradet-Balade; Michael Hahne; Jan Paul Medema
TWE-PRIL; a fusion protein of TWEAK and APRIL.
Bérengère Pradet-Balade; Jan Paul Medema; Marta López-Fraga; jean-claude lozano; Geertruida M Kolfschoten; André Picard; Carlos Martínez-A; Jose A. Garcia-Sanz; Michael Hahne
An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein.
Geertruida M Kolfschoten; Theresia M Hulscher; S M Schrier; Viola M M van Houten; HERBERT PINEDO; Epie Boven
Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Geertruida Kolfschoten (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2003: Geertruida M Kolfschoten; Bérengère Pradet-Balade; Michael Hahne; Jan Paul Medema
TWE-PRIL; a fusion protein of TWEAK and APRIL.
Biochemical pharmacology 2003;66(8):1427-32.
2002: Bérengère Pradet-Balade; Jan Paul Medema; Marta López-Fraga; jean-claude lozano; Geertruida M Kolfschoten; André Picard; Carlos Martínez-A; Jose A. Garcia-Sanz; Michael Hahne
An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein.
The EMBO journal 2002;21(21):5711-20.
2002: Geertruida M Kolfschoten; Theresia M Hulscher; S M Schrier; Viola M M van Houten; HERBERT PINEDO; Epie Boven
Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Gynecologic oncology 2002;84(3):404-12.
2002: Geertruida M Kolfschoten; Theresia M Hulscher; Monique C A Duyndam; HERBERT PINEDO; Epie Boven
Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel.
Biochemical pharmacology 2002;63(4):733-43.
2000: Geertruida M Kolfschoten; Theresia M Hulscher; HERBERT PINEDO; Epie Boven
Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
British journal of cancer 2000;83(7):921-7.
2000: Geertruida M Kolfschoten; HERBERT PINEDO; Peter G Scheffer; Hennie M M Schlüper; C A M Erkelens; Epie Boven
Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
Gynecologic oncology 2000;76(3):362-8.
1997: WJ Jansen; Geertruida M Kolfschoten; C A M Erkelens; J van Ark-Otte; HERBERT PINEDO; Epie Boven
Anti-tumor activity of CPT-11 in experimental human ovarian cancer and human soft-tissue sarcoma.
International journal of cancer. Journal international du cancer 1997;73(6):891-6.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.